Ticker Details
Omeros Corporation Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
IPO Date:	October 8, 2009
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 3.55%
Avg Daily Range (30 D):	$0.51 | 4.10%
Avg Daily Range (90 D):	$0.43 | 3.62%

Institutional Daily Volume
Avg Daily Volume:	.63M
Avg Daily Volume (30 D):	1.88M
Avg Daily Volume (90 D):	1.66M

Trade Size
Avg Trade Size (Sh.):	130
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	79

Institutional Trades
Total Institutional Trades:	1,488
Avg Institutional Trade:	$1.48M
Avg Institutional Trade (30 D):	$1.64M
Avg Institutional Trade (90 D):	$1.85M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.57M
Avg Closing Trade (30 D):	$2.2M
Avg Closing Trade (90 D):	$1.99M
Avg Closing Volume:	128.98K

News

Jul 28, 2026 @ 8:50 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Jul 21, 2026 @ 4:56 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Jul 13, 2026 @ 6:16 PM Omeros Corporation Investigated by the Portnoy Law... Source: Portnoy Law Firm

Jul 8, 2026 @ 9:21 PM Heartflow vs. Omeros: Which Healthcare Innovator S... Source: Brendan Coffey

Jun 20, 2026 @ 3:02 PM Intellia Therapeutics vs. Omeros: Which Emerging B... Source: Brendan Coffey

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.91	$.18	$.78
Diluted EPS	$1.72	$.15	$.62
Revenue	$38.42M	$28.53M	$9.89M
Gross Profit		$27.73M	$9.31M
Net Income / Loss	$124.83M	$13.23M	$56.06M
Operating Income / Loss	$-72.82M	$.07M	$-17.42M
Cost of Revenue		$.8M	$.59M
Net Cash Flow	$.08M	$.08M	$-7.75M
PE Ratio

Splits
Oct 02, 2009	25:49